The search yielded (5) results
Angiotensin II (human),Catalog Number: KS063002,CAS NO.:4474-91-3 Angiotensin II is an endogenous potent vasoconstrictor peptide typically generated by the removal of two residues from angiotensin I by angiotensin-converting enzyme (ACE) by binding to both the AT1 and the AT2 receptors.
Angiotensin I/II (1-7),Catalog Number: KS084006,CAS NO.:51833-78-4 Angiotensin (1-7) exerts vasodilatory effects within the cardiovascular system and plays a crucial function in the renin-angiotensin system. Recently, Angiotensin II (Ang II) has been implicated in preventing SARS-CoV-2 infection by binding to ACE2 receptors in the host cell. Due to the high affinity of SARS-CoV-2 virus to ACE2 receptors, peptide-binding may potentially compete with the virus. Additionally,
Angiotensin I/II (1-7),Catalog Number: KS084006,CAS NO.: 51833-78-4 Angiotensin (1-7) exerts vasodilatory effects within the cardiovascular system and plays a crucial function in the renin-angiotensin system. Recently, Angiotensin II (Ang II) has been implicated in preventing SARS-CoV-2 infection by binding to ACE2 receptors in the host cell. Due to the high affinity of SARS-CoV-2 virus to ACE2 receptors, peptide-binding may potentially compete with the virus. Additionally,
Angiotensin I/II (1-7),Catalog Number: KS084006,CAS NO.:51833-78-4 Angiotensin (1-7) exerts vasodilatory effects within the cardiovascular system and plays a crucial function in the renin-angiotensin system. Recently, Angiotensin II (Ang II) has been implicated in preventing SARS-CoV-2 infection by binding to ACE2 receptors in the host cell. Due to the high affinity of SARS-CoV-2 virus to ACE2 receptors, peptide-binding may potentially compete with the virus. Additionally,
Angiotensin I/II (1-7),Catalog Number: KS084006,CAS NO.:51833-78-4 Angiotensin (1-7) exerts vasodilatory effects within the cardiovascular system and plays a crucial function in the renin-angiotensin system. Recently, Angiotensin II (Ang II) has been implicated in preventing SARS-CoV-2 infection by binding to ACE2 receptors in the host cell. Due to the high affinity of SARS-CoV-2 virus to ACE2 receptors, peptide-binding may potentially compete with the virus. Additionally,
